In detail, there was lower SEPT5 expression in glioblastoma multiforme, head and neck squamous cell carcinoma, kidney chromophobe, stomach adenocarcinoma, and uterine corpus endometrial carcinoma than in normal tissues. This evidence concerns the gene SEPTIN5 and glioblastoma.